Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thymus Gland | 15 | 2015 | 77 | 2.920 |
Why?
|
| T-Lymphocytes | 8 | 2007 | 341 | 0.880 |
Why?
|
| Epithelial Cells | 5 | 2015 | 366 | 0.810 |
Why?
|
| Macrophages, Peritoneal | 2 | 2004 | 22 | 0.450 |
Why?
|
| Cell Biology | 1 | 2011 | 11 | 0.420 |
Why?
|
| Cell Communication | 3 | 2015 | 93 | 0.400 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2007 | 84 | 0.370 |
Why?
|
| Intracellular Space | 1 | 2009 | 35 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 11 | 2009 | 1530 | 0.350 |
Why?
|
| Stem Cells | 1 | 2009 | 132 | 0.340 |
Why?
|
| Apoptosis | 4 | 2001 | 1317 | 0.330 |
Why?
|
| HIV Envelope Protein gp120 | 5 | 2000 | 54 | 0.270 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 608 | 0.260 |
Why?
|
| Mice | 14 | 2009 | 5668 | 0.250 |
Why?
|
| Animals | 21 | 2015 | 14307 | 0.250 |
Why?
|
| Phenotype | 5 | 2015 | 650 | 0.240 |
Why?
|
| Histocompatibility Antigens | 2 | 2015 | 12 | 0.240 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 97 | 0.230 |
Why?
|
| Cell Differentiation | 4 | 2015 | 562 | 0.210 |
Why?
|
| Antigen Presentation | 1 | 2001 | 54 | 0.200 |
Why?
|
| HIV-1 | 5 | 2000 | 678 | 0.180 |
Why?
|
| Peptide Fragments | 4 | 2000 | 298 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2007 | 57 | 0.180 |
Why?
|
| Lysosomes | 1 | 1999 | 80 | 0.170 |
Why?
|
| Major Histocompatibility Complex | 2 | 2009 | 21 | 0.170 |
Why?
|
| Cell Transformation, Viral | 3 | 1991 | 29 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 325 | 0.170 |
Why?
|
| Antibody Specificity | 1 | 1998 | 75 | 0.160 |
Why?
|
| Simian virus 40 | 3 | 1995 | 43 | 0.160 |
Why?
|
| Coculture Techniques | 3 | 2004 | 96 | 0.160 |
Why?
|
| HIV Antibodies | 3 | 2000 | 29 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 1 | 1998 | 282 | 0.140 |
Why?
|
| Lymphocyte Activation | 2 | 2000 | 222 | 0.140 |
Why?
|
| Interleukin-1 | 1 | 1996 | 33 | 0.140 |
Why?
|
| New York | 2 | 2011 | 69 | 0.140 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 55 | 0.130 |
Why?
|
| Autoimmunity | 1 | 2015 | 52 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1996 | 229 | 0.120 |
Why?
|
| Cell Line | 5 | 1999 | 1289 | 0.110 |
Why?
|
| Epitopes | 4 | 1998 | 145 | 0.110 |
Why?
|
| Antigens, CD | 1 | 1992 | 116 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2011 | 74 | 0.100 |
Why?
|
| Awards and Prizes | 1 | 2011 | 27 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2011 | 110 | 0.100 |
Why?
|
| Texas | 1 | 2011 | 299 | 0.090 |
Why?
|
| California | 1 | 2011 | 436 | 0.090 |
Why?
|
| Keratins | 1 | 2009 | 25 | 0.090 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1989 | 20 | 0.090 |
Why?
|
| Transfection | 1 | 1989 | 496 | 0.080 |
Why?
|
| H-Y Antigen | 1 | 2007 | 5 | 0.080 |
Why?
|
| Self Tolerance | 1 | 2007 | 4 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2009 | 360 | 0.080 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 1995 | 138 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 126 | 0.080 |
Why?
|
| HIV Infections | 3 | 1995 | 2207 | 0.070 |
Why?
|
| Endocytosis | 2 | 1999 | 104 | 0.070 |
Why?
|
| Cell Line, Transformed | 2 | 1998 | 87 | 0.070 |
Why?
|
| Humans | 9 | 2015 | 34853 | 0.060 |
Why?
|
| Microscopy, Video | 1 | 2004 | 9 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 1995 | 186 | 0.060 |
Why?
|
| Cell Fusion | 1 | 1984 | 17 | 0.060 |
Why?
|
| Erythrocyte Membrane | 1 | 1984 | 20 | 0.060 |
Why?
|
| Tubulin | 1 | 2004 | 80 | 0.060 |
Why?
|
| Actins | 1 | 2004 | 142 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 240 | 0.060 |
Why?
|
| Lymphocytes | 1 | 1984 | 116 | 0.060 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1982 | 3 | 0.060 |
Why?
|
| Amino Acid Sequence | 5 | 2000 | 1124 | 0.060 |
Why?
|
| Molecular Sequence Data | 5 | 2000 | 1490 | 0.050 |
Why?
|
| Monocytes | 1 | 1984 | 258 | 0.050 |
Why?
|
| Leukocytosis | 1 | 1999 | 3 | 0.050 |
Why?
|
| Cell Degranulation | 1 | 1999 | 10 | 0.050 |
Why?
|
| Point Mutation | 1 | 2000 | 88 | 0.050 |
Why?
|
| Rats | 2 | 2001 | 3261 | 0.040 |
Why?
|
| Molecular Weight | 2 | 1998 | 161 | 0.040 |
Why?
|
| Macrophages | 1 | 2003 | 431 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 35 | 0.040 |
Why?
|
| Growth Inhibitors | 1 | 1998 | 23 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 1998 | 99 | 0.040 |
Why?
|
| Uganda | 2 | 1995 | 22 | 0.040 |
Why?
|
| Organ Specificity | 1 | 1998 | 123 | 0.040 |
Why?
|
| Plasmids | 3 | 2000 | 233 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 1998 | 100 | 0.040 |
Why?
|
| Protein Structure, Secondary | 2 | 2000 | 172 | 0.040 |
Why?
|
| Cross Reactions | 2 | 1995 | 83 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 1998 | 209 | 0.040 |
Why?
|
| Phylogeny | 3 | 1995 | 612 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 1999 | 1442 | 0.040 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1996 | 10 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1995 | 445 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 1996 | 53 | 0.040 |
Why?
|
| Vacuoles | 1 | 1995 | 22 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1995 | 25 | 0.030 |
Why?
|
| Temperature | 2 | 1995 | 275 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1996 | 139 | 0.030 |
Why?
|
| Romania | 1 | 1995 | 6 | 0.030 |
Why?
|
| Antigenic Variation | 1 | 1995 | 9 | 0.030 |
Why?
|
| Male | 4 | 2007 | 18870 | 0.030 |
Why?
|
| Video Recording | 1 | 1993 | 32 | 0.030 |
Why?
|
| Cytoplasm | 1 | 1993 | 135 | 0.030 |
Why?
|
| DNA | 1 | 1995 | 549 | 0.030 |
Why?
|
| Cell Survival | 1 | 1995 | 818 | 0.030 |
Why?
|
| Female | 2 | 2007 | 19873 | 0.030 |
Why?
|
| Mutation | 2 | 1995 | 1023 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1992 | 185 | 0.030 |
Why?
|
| Cell Separation | 1 | 1991 | 91 | 0.020 |
Why?
|
| Moloney murine leukemia virus | 1 | 1989 | 7 | 0.020 |
Why?
|
| Protoplasts | 1 | 1989 | 10 | 0.020 |
Why?
|
| Caseins | 1 | 1989 | 13 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 1989 | 484 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2000 | 649 | 0.020 |
Why?
|
| Gene Expression | 1 | 1989 | 639 | 0.020 |
Why?
|
| Chick Embryo | 2 | 1982 | 71 | 0.020 |
Why?
|
| DNA, Viral | 2 | 2000 | 295 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1996 | 249 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 1996 | 310 | 0.020 |
Why?
|
| Microinjections | 1 | 1984 | 55 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 1984 | 49 | 0.010 |
Why?
|
| Antibodies | 1 | 1984 | 135 | 0.010 |
Why?
|
| New York City | 2 | 1995 | 212 | 0.010 |
Why?
|
| Spleen | 1 | 1984 | 192 | 0.010 |
Why?
|
| Liposomes | 1 | 1984 | 107 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 1982 | 5 | 0.010 |
Why?
|
| Defective Viruses | 1 | 1982 | 10 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1982 | 19 | 0.010 |
Why?
|
| Hyaluronic Acid | 1 | 1982 | 33 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 1982 | 98 | 0.010 |
Why?
|
| Cell Division | 1 | 1982 | 296 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1982 | 166 | 0.010 |
Why?
|
| Alpharetrovirus | 1 | 1980 | 1 | 0.010 |
Why?
|
| Benzopyrenes | 2 | 1978 | 6 | 0.010 |
Why?
|
| Protein Kinases | 1 | 1980 | 91 | 0.010 |
Why?
|
| Cohort Studies | 2 | 1995 | 1422 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2000 | 56 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2000 | 87 | 0.010 |
Why?
|
| Immunization | 1 | 2000 | 90 | 0.010 |
Why?
|
| Viral Proteins | 1 | 1980 | 172 | 0.010 |
Why?
|
| Microsomes, Liver | 2 | 1978 | 69 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2000 | 350 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 485 | 0.010 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 1978 | 49 | 0.010 |
Why?
|
| Viral Vaccines | 1 | 1996 | 28 | 0.010 |
Why?
|
| Species Specificity | 1 | 1996 | 233 | 0.010 |
Why?
|
| Oxazoles | 1 | 1975 | 19 | 0.010 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 1995 | 18 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1995 | 257 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 1995 | 383 | 0.010 |
Why?
|
| Immune Sera | 1 | 1993 | 59 | 0.010 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1995 | 123 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1993 | 53 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 430 | 0.010 |
Why?
|
| Comorbidity | 1 | 1995 | 606 | 0.010 |
Why?
|
| Software | 1 | 1993 | 204 | 0.010 |
Why?
|
| Binding Sites | 1 | 1993 | 597 | 0.010 |
Why?
|
| Base Sequence | 1 | 1993 | 932 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1993 | 328 | 0.010 |
Why?
|
| Risk Factors | 1 | 1995 | 3414 | 0.000 |
Why?
|
| Hexoses | 1 | 1980 | 3 | 0.000 |
Why?
|
| Tyrosine | 1 | 1980 | 109 | 0.000 |
Why?
|
| Phosphoproteins | 1 | 1980 | 154 | 0.000 |
Why?
|
| Ambystoma | 1 | 1978 | 5 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1980 | 878 | 0.000 |
Why?
|
| Proadifen | 1 | 1975 | 1 | 0.000 |
Why?
|
| Depression, Chemical | 1 | 1975 | 4 | 0.000 |
Why?
|
| Benz(a)Anthracenes | 1 | 1975 | 6 | 0.000 |
Why?
|
| NADP | 1 | 1975 | 24 | 0.000 |
Why?
|
| Enzyme Induction | 1 | 1975 | 48 | 0.000 |
Why?
|
| Carbon Monoxide | 1 | 1975 | 30 | 0.000 |
Why?
|
| Mixed Function Oxygenases | 1 | 1975 | 29 | 0.000 |
Why?
|
| Flavonoids | 1 | 1975 | 78 | 0.000 |
Why?
|
| Kinetics | 1 | 1975 | 650 | 0.000 |
Why?
|
| Neoplasms | 1 | 1978 | 1033 | 0.000 |
Why?
|